GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Net Cash per Share

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Net Cash per Share : $0.00 (As of Nov. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Cannabis Bioscience International Holdings's Net Cash per Share for the quarter that ended in Nov. 2023 was $0.00.

The historical rank and industry rank for Cannabis Bioscience International Holdings's Net Cash per Share or its related term are showing as below:

CBIH's Price-to-Net-Cash is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.13
* Ranked among companies with meaningful Price-to-Net-Cash only.

Cannabis Bioscience International Holdings Net Cash per Share Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Net Cash per Share Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11
Net Cash per Share
-0.13 0.02 -8.52 -1.76 -2.38

Cannabis Bioscience International Holdings Semi-Annual Data
Dec06 Jun07 Dec07 Jun08 May09 Nov09 May10 Nov10 May11 Nov11 Nov22 Nov23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.18 -2.38 -2.90 - -

Competitive Comparison of Cannabis Bioscience International Holdings's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Price-to-Net-Cash falls into.



Cannabis Bioscience International Holdings Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Cannabis Bioscience International Holdings's Net Cash per Share for the fiscal year that ended in May. 2011 is calculated as

Net Cash per Share (A: May. 2011 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0.137-27.974-2.905)/12.9306
=-2.38

Cannabis Bioscience International Holdings's Net Cash per Share for the quarter that ended in Nov. 2023 is calculated as

Net Cash per Share (Q: Nov. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(0-0.944-0)/10331.7
=-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Cannabis Bioscience International Holdings Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Headlines

From GuruFocus

CHNC Completes Review of Its First Three Fiscal Quarters

By PurpleRose PurpleRose 07-12-2022